Innospec (NASDAQ:IOSP) Reaches New 12-Month Low – Here’s Why

Innospec Inc. (NASDAQ:IOSPGet Free Report) hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $102.29 and last traded at $101.55, with a volume of 8113 shares changing hands. The stock had previously closed at $109.88.

Wall Street Analyst Weigh In

Separately, StockNews.com cut Innospec from a “strong-buy” rating to a “buy” rating in a research note on Saturday, January 11th.

Check Out Our Latest Research Report on Innospec

Innospec Stock Performance

The company has a market capitalization of $2.51 billion, a price-to-earnings ratio of 17.59 and a beta of 1.09. The firm has a 50-day simple moving average of $111.79 and a two-hundred day simple moving average of $112.74.

Innospec (NASDAQ:IOSPGet Free Report) last announced its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.05. Innospec had a net margin of 7.68% and a return on equity of 13.33%. The firm had revenue of $466.80 million during the quarter, compared to analysts’ expectations of $447.43 million. As a group, equities analysts forecast that Innospec Inc. will post 5.87 EPS for the current fiscal year.

Institutional Trading of Innospec

A number of large investors have recently modified their holdings of IOSP. Blue Trust Inc. increased its holdings in Innospec by 503.9% during the 3rd quarter. Blue Trust Inc. now owns 779 shares of the specialty chemicals company’s stock worth $96,000 after purchasing an additional 650 shares during the period. Murphy & Mullick Capital Management Corp purchased a new stake in shares of Innospec during the fourth quarter worth approximately $106,000. Covestor Ltd raised its holdings in Innospec by 13.9% in the fourth quarter. Covestor Ltd now owns 967 shares of the specialty chemicals company’s stock valued at $106,000 after acquiring an additional 118 shares in the last quarter. KBC Group NV lifted its stake in Innospec by 82.3% in the fourth quarter. KBC Group NV now owns 1,236 shares of the specialty chemicals company’s stock worth $136,000 after acquiring an additional 558 shares during the last quarter. Finally, Smartleaf Asset Management LLC grew its holdings in Innospec by 91.9% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,802 shares of the specialty chemicals company’s stock worth $198,000 after acquiring an additional 863 shares in the last quarter. Hedge funds and other institutional investors own 96.64% of the company’s stock.

Innospec Company Profile

(Get Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Read More

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.